Issue 83, 2015

Acid/redox dual-activated liposomes for tumor-targeted drug delivery and enhanced therapeutic efficacy

Abstract

Acid/redox dual-activated liposomes consisting of a synthetic functional lipid were developed to overcome the multiple barriers to the intravenous delivery of an anticancer drug from the injection site to the target site. The liposome exhibited tumor pH-promoted cellular uptake, endocytic pH-responsive endo-lysosomal escape and redox-triggered intracellular drug release, thereby yielding enhanced antitumor activity.

Graphical abstract: Acid/redox dual-activated liposomes for tumor-targeted drug delivery and enhanced therapeutic efficacy

Supplementary files

Article information

Article type
Communication
Submitted
10 Apr 2015
Accepted
31 Jul 2015
First published
07 Aug 2015

RSC Adv., 2015,5, 67803-67808

Acid/redox dual-activated liposomes for tumor-targeted drug delivery and enhanced therapeutic efficacy

X. Xu, L. Zhang, A. G. Assanhou, L. Wang, Y. Zhang, W. Li, L. Xue, R. Mo and C. Zhang, RSC Adv., 2015, 5, 67803 DOI: 10.1039/C5RA06445G

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements